Personalized Medicine for Genetic Diseases
Developing personalized medicine to treat genetic diseases is a growing frustration among patients who have limited treatment options. By leveraging genetic testing and advanced technologies, personalized medicine can provide targeted therapies tailored to individuals. Market size: According to a report by Grand View Research, the global personalized medicine market size is expected to reach $3.6 billion by 2026, with a compound annual growth rate of 8.5%. Tags: personalized medicine, genetic diseases, genetic testing, targeted therapies. Country: United States, Germany, United Kingdom, Japan. Category: Healthcare.
Targeted therapies
United States
